Shenzhen - Delayed Quote CNY

Pacific Shuanglin Bio-pharmacy Co., LTD (000403.SZ)

29.85 +0.16 (+0.54%)
At close: 3:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Hua Gang Yuan GM & Non-Independent Director -- -- 1973
Ms. Yehong Wang Chief Financial Officer -- -- 1991
Mr. Di Wu Deputy GM & Non-Independent Director -- -- 1983
Mr. Yulin Zhao Board Secretary -- -- 1987
Mr. Zhi Bo Wang Deputy General Manager -- -- 1984
Mr. Bin Yang Deputy General Manager -- -- 1982
Mr. Lei Yan Deputy General Manager -- -- 1991

Pacific Shuanglin Bio-pharmacy Co., LTD

Sunshine City Global Financial Center
Room 3004 No. 8, Changxing South Street Jinyuan District
Taiyuan
China
https://www.slbiop.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), hepatitis B human immunoglobulin, tetanus human immunoglobulin, rabies patient immunoglobulin, and human coagulation factor. addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; and electronic product information consultation. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. was founded in 1993 and is based in Taiyuan, China.

Corporate Governance

Pacific Shuanglin Bio-pharmacy Co., LTD’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Jul 20, 2023
    Ex-Dividend Date

Upcoming Events

Related Tickers

688658.SS Youcare Pharmaceutical Group Co., Ltd.
15.55
+3.74%
 
688075.SS Assure Tech (Hangzhou) Co., Ltd.
32.95
-0.24%
 
688767.SS Hangzhou Biotest Biotech Co.,Ltd.
25.19
+0.76%
 
603229.SS Zhejiang Ausun Pharmaceutical Co., Ltd.
10.40
+3.07%
 
300049.SZ Inner Mongolia Furui Medical Science Co., Ltd.
49.73
-1.74%
 
002873.SZ Guiyang Xintian Pharmaceutical Co.,Ltd.
11.38
+0.26%
 
688105.SS Nanjing Vazyme Biotech Co.,Ltd
25.79
+0.74%
 
300583.SZ Shandong Sito Bio-technology Co., Ltd.
13.45
+1.28%
 
688046.SS GemPharmatech Co., Ltd.
12.10
+1.77%
 
300255.SZ Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
11.77
+19.98%